Metasphere Labs Inc.
LABZ
CNSX
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -14.60K | -14.60K | 1.20K | 1.20K | 174.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -14.60K | -14.60K | 1.20K | 1.20K | 174.60K |
| Cost of Revenue | -13.80K | -13.80K | 1.20K | 1.20K | 40.50K |
| Gross Profit | -800.00 | -800.00 | 100.00 | 100.00 | 134.30K |
| SG&A Expenses | 325.50K | 442.60K | 453.70K | 562.50K | 711.80K |
| Depreciation & Amortization | -- | -- | -- | -- | 32.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 336.60K | 442.60K | 468.80K | 593.00K | 820.50K |
| Operating Income | -351.10K | -457.10K | -467.40K | -591.60K | -645.80K |
| Income Before Tax | -429.70K | -506.50K | -517.90K | -655.40K | -1.20M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.43 | -0.51 | -0.52 | -0.66 | -1.20 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -429.70K | -506.50K | -517.90K | -655.40K | -1.20M |
| EBIT | -351.10K | -457.10K | -467.40K | -591.60K | -645.80K |
| EBITDA | -142.70K | -313.40K | -380.70K | -573.80K | -627.90K |
| EPS Basic | -0.04 | -0.05 | -0.05 | -0.07 | -0.14 |
| Normalized Basic EPS | -0.02 | -0.03 | -0.03 | -0.04 | -0.05 |
| EPS Diluted | -0.04 | -0.05 | -0.05 | -0.07 | -0.14 |
| Normalized Diluted EPS | -0.02 | -0.03 | -0.03 | -0.04 | -0.05 |
| Average Basic Shares Outstanding | 47.63M | 42.34M | 41.73M | 40.24M | 37.37M |
| Average Diluted Shares Outstanding | 47.63M | 42.34M | 41.73M | 40.24M | 37.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |